ICN is a privately-owned corporation with an experienced management team and the support of Early Stage Partners, a Cleveland-based venture capital firm.

Early Stage Partners is one of the largest and most active early stage venture funds in Ohio, with $100 million under management. The Partnership’s investments in the life sciences, advanced materials, information technology and advanced energy sectors have resulted in significant returns for the fund’s investors. In 2014 alone, portfolio companies TOA Technologies, Simbionix and Reverse Medical were sold to strategic investors for a combined value approaching $750 million. The company’s principals have over 100 years combined experience in early stage company formation and development, and significant operating experience, which allows them to contribute to the success of companies like ICN.